NCT04923269View on ClinicalTrials.gov

A Study of LY3532226 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

October 28, 2021

Study Completion Date

October 28, 2021

Conditions

Healthy

Interventions

DRUG

LY3532226

Administered SC.

DRUG

Placebo

Administered SC.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY